Bausch Health Companies Inc. (BHC) financial statements (2021 and earlier)

Company profile

Business Address 2150 ST. ELZEAR BLVD. WEST
QUEBEC, QC H7L 4A8
State of Incorp. NJ
Fiscal Year End December 31
SIC 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in millions)
Annual | Quarterly

12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
12/31/2013
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments3,243721720542597323600
Cash and cash equivalents3,243721720542597323600
Restricted cash and investments1277    
Receivables1,8391,8652,1302,5172,6872,0761,815
Inventory, net of allowances, customer advances and progress billings1,1079341,0481,0611,257951883
Inventory1,1079341,0481,0611,257951883
Prepaid expense  7820 9
Disposal group, including discontinued operation   261 9 
Assets held-for-sale✕✕✕✕✕✕16
Deferred tax assets✕    193367
Other undisclosed current assets779689764688946642196
Total current assets:6,9694,2114,7465,0775,5074,1933,886
Noncurrent Assets
Property, plant and equipment1,4661,3531,4031,3121,4421,3111,234
Intangible assets, net (including goodwill)23,32725,14330,80434,67841,63620,60222,600
Goodwill13,12613,14215,59315,79418,5539,3469,752
Intangible assets, net (excluding goodwill)10,20112,00115,21118,88423,08311,25612,848
Disposal group, including discontinued operation, noncurrent assets  122,132  ✕
Deferred income tax assets1,690✕✕✕✕✕✕
Other noncurrent assets41110999184224193195
Other undisclosed noncurrent assets 1,6764331461565455
Total noncurrent assets:26,89428,28132,75138,45243,45722,16024,085
TOTAL ASSETS:33,86332,49237,49743,52948,96526,35327,971
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities5,0143,6084,0593,4994,2933,1272,192
Accounts payable503411365324434398327
Accrued liabilities4,5113,1973,6943,1753,8592,1791,800
Employee-related liabilities     205 
Taxes payable     14865
Interest and dividends payable     197 
Debt1,23422820918237217
Restructuring reserve     67✕
Liability for uncertainty in income taxes     79
Estimated litigation liability     856
Disposal group, including discontinued operation   57   
Business combination, contingent consideration, liability   52197142✕
Deferred tax liabilities✕    1166
Other undisclosed current liabilities     (637)(27)
Total current liabilities:6,2483,8364,2683,6095,3132,7312,512
Noncurrent Liabilities
Long-term debt and lease obligation24,66124,07725,23529,84530,26515,25417,163
Long-term debt, excluding current maturities24,66124,07725,23529,84530,26515,25417,163
Liabilities, other than long-term debt1,5568798906,8176,3982,7672,821
Pension and other postretirement defined benefit plans, liabilities✕✕✕✕✕✕172
Deferred tax liabilities, net✕  5,4345,9022,2282,319
Deferred income tax liabilities705✕✕✕✕✕✕
Liability for uncertainty in income taxes   184120103169
Liability, pension and other postretirement and postemployment benefits   195190240✕
Estimated litigation liability  20    
Disposal group, including discontinued operation, liabilities   57   
Other liabilities851581526107185197160
Business combination, contingent consideration, liability 298344840  ✕
Other undisclosed noncurrent liabilities2628851,160 959167241
Total noncurrent liabilities:26,47925,84127,28536,66237,62218,18820,225
Total liabilities:32,72729,67731,55340,27142,93520,91922,737
Stockholders' equity
Stockholders' equity attributable to parent1,0632,7335,8493,1525,9115,3125,119
Common stock10,17210,12110,09010,0389,8978,3498,301
Additional paid in capital429413380351305244229
Accumulated other comprehensive loss(2,086)(2,137)(1,896)(2,108)(1,542)(916)(133)
Accumulated deficit(7,452)(5,664)(2,725)(5,129)(2,750)(2,365)(3,279)
Stockholders' equity attributable to noncontrolling interest738295106119122115
Total stockholders' equity:1,1362,8155,9443,2586,0305,4355,233
TOTAL LIABILITIES AND EQUITY:33,86332,49237,49743,52948,96526,35327,971

Income statement (P&L) ($ in millions)
Annual | Quarterly

12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
12/31/2013
Revenues8,6018,3808,7249,67410,4478,2645,770
Revenue, net✕✕8,7249,67410,4478,2645,693
Cost of revenue(5,673)(7,287)(4,908)(3,555)(5,485)(2,255)(1,905)
Cost of goods and services sold  (2,548)(2,611)(2,585)(2,255)(1,905)
Gross profit:2,9281,0933,8166,1194,9626,0093,864
Operating expenses(3,131)(3,477)(3,714)(6,685)(3,435)(4,121)(4,413)
Other operating income (expense), net(1,414)21353 (256)269234
Other expenses      234
Other undisclosed operating income (loss)1,414(21)(353) 256(117)(95)
Operating income (loss):(203)(2,384)102(566)1,5272,040(410)
Nonoperating income (expense)2034119(33)(100)1544
Investment income, nonoperating1211128329814
Foreign currency transaction gain (loss), before tax823107(41)(103)(144)(9)
Interest and debt expense(1,612)(1,685)(1,840)(1,836)(1,563)(971)(844)
Other undisclosed loss from continuing operations before equity method investments, income taxes(42)(119)(122) (20)(130)(65)
Income (loss) from continuing operations before income taxes:(1,837)(4,154)(1,741)(2,435)(155)1,093(1,314)
Income tax expense (benefit)54104,14527(133)(180)451
Net income (loss):(1,783)(4,144)2,404(2,408)(288)912(864)
Net income (loss) attributable to noncontrolling interest(5)(4) (1)(4)1(2)
Net income (loss) available to common stockholders, diluted:(1,788)(4,148)2,404(2,409)(292)914(866)

Comprehensive Income ($ in millions)
Annual | Quarterly

12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
12/31/2013
Net income (loss):(1,783)(4,144)2,404(2,408)(288)912(864)
Other comprehensive income (loss)50(244)217(571)(630)(690) 
Other undisclosed comprehensive loss     (94)(13)
Comprehensive income (loss):(1,733)(4,388)2,621(2,979)(917)128(877)
Comprehensive income (loss), net of tax, attributable to noncontrolling interest(4)(1)(4)4(0)33
Other undisclosed comprehensive loss, net of tax, attributable to parent      (6)
Comprehensive income (loss), net of tax, attributable to parent:(1,737)(4,389)2,617(2,975)(917)130(880)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: